Waters Corp. (WAT) – Company Press Releases
-
Waters Accelerates the Development of Gene-based Therapeutics with New GTxResolve Premier SEC Columns
-
Waters Corporation Schedules First Quarter 2024 Earnings Conference Call
-
Waters Launches Alliance iS Bio HPLC System to Help Biopharma QC Labs Increase Efficiency and Reduce Errors
-
Waters Streamlines and Expedites PFAS Testing with Innovative Oasis Dual-Phase Cartridges
-
Waters Advances Battery Electrode Design and Performance Analysis with New Rheo-IS Accessory
-
Waters Announces Seamless HPLC/UPLC Data Bridge for Light Scattering, Integrating Essential Instruments for Large Molecule Characterization
-
Waters Corporation to Present at the TD Cowen 44th Annual Health Care Conference
-
Waters Corporation (NYSE: WAT) Reports Fourth Quarter and Full-Year 2023 Financial Results
-
Waters Corporation Schedules Fourth Quarter 2023 Earnings Conference Call
-
Waters Corporation to Present at the 42nd Annual J.P. Morgan Healthcare Conference
-
Waters Earns Sustainability Designation from My Green Lab for Xevo TQ Absolute System
-
Waters Corporation Named to Dow Jones Sustainability Index for the Third Consecutive Year
-
Waters Corporation Board of Directors Named 2024 Public Company Board of the Year by National Association of Corporate Directors New England Chapter
-
NACD New England honors Waters Corp. and Devoted Health as Public and Private Company “Boards of the Year”
-
Waters Corporation Opens New State-of-the-Art Global Capability Center in Bengaluru, India
-
Waters Earns Top Score in Human Rights Campaign Foundation's 2023-2024 Corporate Equality Index
-
Waters Corporation to Present at the Evercore ISI HealthCONx 2023 Health Care Conference
-
WATERS 2023 ESG REPORT HIGHLIGHTS CONTINUED PROGRESS TOWARDS SUSTAINABILITY COMMITMENTS
-
Waters Corporation (NYSE: WAT) Reports Third Quarter 2023 Financial Results
-
Waters Corporation Announces Business Unit Leadership Transition
-
Waters Accelerates Oligonucleotide Bioanalysis with the Launch of OligoWorks™ SPE Workflow and Kits
-
Waters Corporation Schedules Third Quarter 2023 Earnings Conference Call
-
Waters ZetaStar Instrument Boosts Speed and Sensitivity of Light Scattering Measurements for Biological Therapies
-
Waters Launches New Walk-up Solutions that Further Simplify the Analysis of Biologic Drug Product and Cell Culture Media
-
Waters Corporation to Present at the Bank of America Global Healthcare Conference 2023
-
Waters Corporation (NYSE: WAT) Reports Second Quarter 2023 Financial Results
-
Waters Launches XBridge Premier GTx BEH SEC Columns for Gene Therapy Applications
-
Waters Corporation Schedules Second Quarter 2023 Earnings Conference Call
-
Waters Corporation and Princeton University Announce Multi-Year Research Collaboration
-
Waters Corporation Named to U.S. News & World Report's 2023-2024 Best Companies to Work For
-
Waters Boosts Resolution and Triples Scan Speed of SELECT SERIES MRT for Metabolomics and MS Imaging
-
Waters Takes Targeted, Quantitative Imaging to the Next Level with New DESI Source for the Xevo TQ Absolute System
-
Waters and Sartorius Expand Collaboration to Deliver Comprehensive Bioanalytics for Downstream Biomanufacturing
-
Waters Corporation to Present at the Jefferies 2023 Healthcare Conference
-
Waters Corporation Completes Acquisition of Light Scattering Leader Wyatt Technology
-
Waters Corporation (NYSE: WAT) Reports First Quarter 2023 Financial Results
-
Waters Corporation Schedules First Quarter 2023 Earnings Conference Call
-
Waters Launches its Most Sensitive and Compact Clinical IVD System with Xevo TQ Absolute IVD Mass Spectrometer
-
Waters Corporation Appoints Richard Fearon to Board of Directors
-
Waters Introduces Next-Generation Alliance iS HPLC System Aimed at Reducing Up to 40% of Common Lab Errors
-
Waters’ New Battery Cycler Microcalorimeter Solution Accelerates Real-World Testing from Months to Weeks
-
Waters Corporation Listed as No. 5 on Barron's 100 Most Sustainable Companies 2023 List
-
Waters Corporation Presentation at the Cowen 43rd Annual Health Care Conference to be Webcast Live
-
Waters Corporation (NYSE: WAT) Reports Fourth Quarter and Full-Year 2022 Financial Results
-
Waters Corporation to Acquire Wyatt Technology, Light Scattering Instrument and Software Leader
-
New waters_connect System Monitoring Software Maximizes Productivity with Real-Time, Cloud-Native Lab Management
-
Waters Corporation Schedules Fourth Quarter 2022 Earnings Conference Call
-
Waters Corporation Recognized for its Award-winning Products, Outstanding Leadership, and ESG Progress
-
Waters Corporation Presentation at the 41st Annual J.P. Morgan Healthcare Conference to Be Audio Webcast Live
-
Waters Corporation Presentation at the 41st Annual J.P. Morgan Healthcare Conference to Be Audio Webcast Live
Back to WAT Stock Lookup